Abingworth — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Iambic Therapeutics, Inc.Sep 2023SEC filingmedium confidence
BiotechSan Diego, US
Fred Manby(Executive Officer, Director)inThomas Miller(Executive Officer, Director)inNeil Josephson(Executive Officer)Michael Secora(Executive Officer)Pete Olson(Executive Officer)Chao Zhang(Executive Officer)
Board seatKurt von Emster· per SEC Form D · $50M raise · filed Apr 2026
Co-investorsNexus Venture PartnersNexus Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.